By identifying a total of 760 differentially expressed mRNA genes associated with TGF-β, we used Pearson correlation test between gene expression and 50% inhibiting concentration (IC50) for 345 anticancer drugs to assess drug response across 106 digestive tract cancer cell lines from the Genomics of Drug Sensitivity in Cancer (GDSC). This evidence concerns the gene TGFB1 and cancer.